ADVFN - ニュース

S&P 500

5,267.84

-0.74%

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/24	06 : 00	Business Wire	Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:GMAB	Genmab AS
2024/05/24	06 : 00	Business Wire	Merck to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
2024/05/24	06 : 00	GlobeNewswire Inc.	IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2024 ASCO Annual Meeting	NASDAQ:INAB	IN8bio Inc
2024/05/24	06 : 00	Business Wire	Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA	NASDAQ:LEGN	Legend Biotech Corporation
2024/05/24	06 : 00	Business Wire	SOTIO Presents Overview of DUET-01 Phase 1/2 Study at ASCO Annual Meeting
2024/05/24	06 : 00	GlobeNewswire Inc.	Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Advanced Non-Small Cell Lung Cancer (NSCLC) in Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment at 2024 ASCO Annual Meeting	NASDAQ:CADL	Candel Therapeutics Inc
2024/05/24	06 : 00	GlobeNewswire Inc.	Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m HNSCC at the 2024 ASCO® Annual Meeting	TG:2GH	Merus NV
2024/05/24	06 : 00	GlobeNewswire Inc.	Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:BPTH	Bio Path Holdings Inc
2024/05/24	06 : 00	GlobeNewswire Inc.	Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024	NASDAQ:EVAX	Evaxion Biotech AS
2024/05/24	06 : 00	Business Wire	Obsidian Therapeutics Announces Positive Clinical Data from OBX-115 in Patients with Advanced Melanoma at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
2024/05/24	06 : 00	GlobeNewswire Inc.	Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting	NASDAQ:MURA	Mural Oncology PLC
2024/05/24	06 : 00	Business Wire	Dentalcorp Announces Annual General Meeting Voting Results	TSX:DNTL	dentalcorp Holdings Ltd
2024/05/24	06 : 00	GlobeNewswire Inc.	Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024
2024/05/24	06 : 00	GlobeNewswire Inc.	MAQUIA CAPITAL ACQUISITION CORPORATION AND IMMERSED INC. MUTUALLY AGREE TO TERMINATE BUSINESS COMBINATION AGREEMENT	NASDAQ:MAQC	Maquia Capital Acquisition Corporation
2024/05/24	06 : 00	GlobeNewswire Inc.	Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/05/24	06 : 00	Business Wire	Klaviyo to Present at the William Blair Growth Stock Conference	NYSE:KVYO	Klaviyo Inc
2024/05/24	06 : 00	GlobeNewswire Inc.	Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m HNSCC at the 2024 ASCO® Annual Meeting	NASDAQ:MRUS	Merus NV
2024/05/24	06 : 00	Business Wire	Orca Bio to Present Positive Clinical Outcomes with Orca-T in Patients with AML at 2024 ASCO Annual Meeting
2024/05/24	06 : 00	GlobeNewswire Inc.	Timbercreek Financial Declares May 2024 Dividend	TSX:TF	Timbercreek Financial Corp
2024/05/24	06 : 00	Business Wire	NeraCare Announces Publication of Abstract on Clinical Validation of a Prognostic 7-Biomarker Assay for Prediction of Relapse in Patients with Early-Stage Cutaneous Melanoma at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
2024/05/24	06 : 00	GlobeNewswire Inc.	Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors	TSX:TH	Theratechnologies Inc
2024/05/24	06 : 00	GlobeNewswire Inc.	Tizona Therapeutics Presents Phase 1b TTX-080 Clinical Data in Advanced Colorectal Cancer and Head and Neck Squamous Cell Carcinoma at ASCO 2024
2024/05/24	06 : 00	Business Wire	Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting
2024/05/24	06 : 00	GlobeNewswire Inc.	Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual Meeting	TG:2GH	Merus NV
2024/05/24	06 : 00	Business Wire	Iambic Therapeutics Announces Poster Presentation for IAM1363, a Clinical Stage Type II HER2 Inhibitor, at the 2024 ASCO Annual Meeting
2024/05/24	06 : 00	Business Wire	Xspray to present data at ASCO highlighting frequent comedication of PPIs with TKIs in CML-patients and greater than expected negative effects on the bioavailability of crystalline dasatinib
2024/05/24	06 : 00	Business Wire	EMD Serono to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
2024/05/24	06 : 00	GlobeNewswire Inc.	Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:REPL	Replimune Group Inc
2024/05/24	06 : 00	GlobeNewswire Inc.	Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting	TG:GE9	Genmab AS
2024/05/24	06 : 00	GlobeNewswire Inc.	NVIDIA Announces Upcoming Event for Financial Community	NASDAQ:NVDA	NVIDIA Corporation